Abstract
Lipid mediators, such as prostanoids and leukotrienes, are metabolites of arachidonic acid released in various pathophysiological conditions that exert a range of actions mediated through their respective receptors expressed on target cells. Although it has been difficult to analyze the physiological role of prostanoids or leukotrienes, recent developments in the disruption of both the respective genes and receptor-selective compounds have enabled us to investigate the physiological roles for lipid mediators. It has been demonstrated that each receptor of lipid mediators has multiple functions in a context-dependent manner, which sometimes results in opposite—excitatory and inhibitory—outcomes. The balance of the production and the receptor expression of each lipid mediator has been proved to be important for maintaining the homeostasis of our body. Here, we review new findings on the functions of prostanoids and leukotrienes in skin inflammatory diseases, focusing on contact dermatitis, atopic dermatitis, and psoriasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pasparakis M, Haase I, Nestle FO (2014) Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 14(5):289–301. doi:10.1038/nri3646
Heath WR, Carbone FR (2013) The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 14(10):978–985. doi:10.1038/ni.2680
Honda T, Tokura Y, Miyachi Y, Kabashima K (2010) Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology. Curr Drug Targets 11(12):1605–1613
Hirata T, Narumiya S (2012) Prostanoids as regulators of innate and adaptive immunity. Adv Immunol 116:143–174. doi:10.1016/B978-0-12-394300-2.00005-3
Yokomizo T (2011) Leukotriene B4 receptors: novel roles in immunological regulations. Adv Enzyme Regul 51(1):59–64. doi:10.1016/j.advenzreg.2010.08.002
Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193–1226
Honda T, Egawa G, Grabbe S, Kabashima K (2013) Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 133(2):303–315. doi:10.1038/jid.2012.284
Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, Johansen JD, Karlberg AT, Kimber I, Lepoittevin JP, Liebsch M, Maibach HI, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel RJ, White IR, Luch A (2012) Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci 69(5):763–781. doi:10.1007/s00018-011-0846-8
Kabashima K, Sakata D, Nagamachi M, Miyachi Y, Inaba K, Narumiya S (2003) Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9(6):744–749. doi:10.1038/nm872
Shiraishi N, Nomura T, Tanizaki H, Nakajima S, Narumiya S, Miyachi Y, Tokura Y, Kabashima K (2013) Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions. PLoS One 8(7):e69599. doi:10.1371/journal.pone.0069599
Del Prete A, Shao WH, Mitola S, Santoro G, Sozzani S, Haribabu B (2007) Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 109(2):626–631. doi:10.1182/blood-2006-02-003665
Angeli V, Staumont D, Charbonnier AS, Hammad H, Gosset P, Pichavant M, Lambrecht BN, Capron M, Dombrowicz D, Trottein F (2004) Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 172(6):3822–3829
Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, Capron A, Wolowczuk I, Capron M, Trottein F (2001) Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 193(10):1135–1147
Yamamoto Y, Otani S, Hirai H, Nagata K, Aritake K, Urade Y, Narumiya S, Yokozeki H, Nakamura M, Satoh T (2011) Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. Am J Pathol 179(1):302–314. doi:10.1016/j.ajpath.2011.03.047
Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ (2000) The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103(5):757–768
Nagamachi M, Sakata D, Kabashima K, Furuyashiki T, Murata T, Segi-Nishida E, Soontrapa K, Matsuoka T, Miyachi Y, Narumiya S (2007) Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J Exp Med 204(12):2865–2874. doi:10.1084/jem.20070773
Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, Sugimoto Y, Narumiya S (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15(6):633–640. doi:10.1038/nm.1968
Nakajima S, Honda T, Sakata D, Egawa G, Tanizaki H, Otsuka A, Moniaga CS, Watanabe T, Miyachi Y, Narumiya S, Kabashima K (2010) Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J Immunol 184(10):5595–5603. doi:10.4049/jimmunol.0903260
Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, Yoshida N, Katagiri K, Kinashi T, Tanaka T, Miyasaka M, Nagai H, Ushikubi F, Narumiya S (2003) Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 4(7):694–701. doi:10.1038/ni943
Kanda N, Mitsui H, Watanabe S (2004) Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 114(6):1403–1409. doi:10.1016/j.jaci.2004.08.041
Takeshita K, Yamasaki T, Nagao K, Sugimoto H, Shichijo M, Gantner F, Bacon KB (2004) CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 16(7):947–959. doi:10.1093/intimm/dxh096
Boehme SA, Chen EP, Franz-Bacon K, Sasik R, Sprague LJ, Ly TW, Hardiman G, Bacon KB (2009) Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms. Int Immunol 21(1):1–17. doi:dxn118
Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S (2009) Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol 124(4):809–818 e802. doi:10.1016/j.jaci.2009.04.029
Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4(10):965–973. doi:10.1038/ni972
Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4(10):982–990. doi:10.1038/ni970
Kanda N, Watanabe S (2007) Leukotriene B4 enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes. Clin Exp Allergy 37(7):1074–1082. doi:10.1111/j.1365-2222.2007.02743.x
Fogh K, Herlin T, Kragballe K (1989) Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 83(2 pt 1):450–455
Laouini D, Elkhal A, Yalcindag A, Kawamoto S, Oettgen H, Geha RS (2005) COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. J Allergy Clin Immunol 116(2):390–396. doi:10.1016/j.jaci.2005.03.042
Fedyk ER, Phipps RP (1996) Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A 93(20):10978–10983
He R, Oyoshi MK, Wang JY, Hodge MR, Jin H, Geha RS (2010) The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge. J Allergy Clin Immunol 126(4):784–790. doi:10.1016/j.jaci.2010.07.006
Matsushima Y, Satoh T, Yamamoto Y, Nakamura M, Yokozeki H (2011) Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. Mol Immunol 49(1-2):304–310. doi:10.1016/j.molimm.2011.08.023
Sarashina H, Tsubosaka Y, Omori K, Aritake K, Nakagawa T, Hori M, Hirai H, Nakamura M, Narumiya S, Urade Y, Ozaki H, Murata T (2014) Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. J Immunol 192(1):459–465. doi:10.4049/jimmunol.1302080
Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, Yokozeki H, Hirai H, Nagata K, Hara T, Utsuyama M, Hirokawa K, Sugamura K, Nishioka K, Nakamura M (2006) Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177(4):2621–2629
Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193(2):255–261
Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, Nagase H, Ishii A, Matsushima K, Yamamoto K, Shichijo M, Bacon KB, Hirai K (2004) Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 34(8):1283–1290. doi:10.1111/j.1365-2222.2004.02027.x
Iwasaki M, Nagata K, Takano S, Takahashi K, Ishii N, Ikezawa Z (2002) Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 119(3):609–616. doi:10.1046/j.1523-1747.2002.01862.x
Oyoshi MK, He R, Li Y, Mondal S, Yoon J, Afshar R, Chen M, Lee DM, Luo HR, Luster AD, Cho JS, Miller LS, Larson A, Murphy GF, Geha RS (2012) Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity 37(4):747–758. doi:10.1016/j.immuni.2012.06.018
Neisius U, Olsson R, Rukwied R, Lischetzki G, Schmelz M (2002) Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol 47(1):28–32
Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, Takahashi N, Inoue T, Nakaike S (2004) Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 505(1-3):229–235. doi:10.1016/j.ejphar.2004.10.031
Andoh T, Haza S, Saito A, Kuraishi Y (2011) Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp Dermatol 20(11):894–898. doi:10.1111/j.1600-0625.2011.01346.x
Andoh T, Nishikawa Y, Yamaguchi-Miyamoto T, Nojima H, Narumiya S, Kuraishi Y (2007) Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol 127(8):2042–2047. doi:10.1038/sj.jid.5700810
Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6(12):704–714. doi:10.1038/nrrheum.2010.157
Ikai K (1999) Psoriasis and the arachidonic acid cascade. J Dermatol Sci 21(3):135–146
van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9):5836–5845. doi:10.4049/jimmunol.0802999
Sumida H, Yanagida K, Kita Y, Abe J, Matsushima K, Nakamura M, Ishii S, Sato S, Shimizu T (2014) Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis. J Immunol 192(9):4361–4369. doi:10.4049/jimmunol.1302959
Schirmer C, Klein C, von Bergen M, Simon JC, Saalbach A (2010) Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 116(10):1715–1725. doi:10.1182/blood-2010-01-263509
Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D (2004) Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 18(11):1318–1320. doi:10.1096/fj.03-1367fje
Ofuji S, Furukawa F, Miyachi Y, Ohno S (1984) Papuloerythroderma. Dermatologica 169(3):125–130
Nakahigashi K, Doi H, Otsuka A, Hirabayashi T, Murakami M, Urade Y, Zouboulis CC, Tanizaki H, Egawa G, Miyachi Y, Kabashima K (2012) PGD2 induces eotaxin-3 via PPAR-gamma from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol 129(2):536–543. doi:10.1016/j.jaci.2011.11.034
Sugita K, Ikenouchi-Sugita A, Nakayama Y, Yoshioka H, Nomura T, Sakabe J, Nakahigashi K, Kuroda E, Uematsu S, Nakamura J, Akira S, Nakamura M, Narumiya S, Miyachi Y, Tokura Y, Kabashima K (2013) Prostaglandin E2 is critical for the development of niacin-deficiency-induced photosensitivity via ROS production. Sci Rep 3:2973. doi:10.1038/srep02973
Kabashima K, Nagamachi M, Honda T, Nishigori C, Miyachi Y, Tokura Y, Narumiya S (2007) Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors. Lab Invest J Tech Methods Pathol 87(1):49–55. doi:10.1038/labinvest.3700491
Williams TJ, Morley J (1973) Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246(5430):215–217
Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T, Kabashima K, Tanaka S, Murakami M, Narumiya S, Sugimoto Y (2014) Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J Immunol 192(3):1130–1137. doi:10.4049/jimmunol.1300290
Goulet JL, Pace AJ, Key ML, Byrum RS, Nguyen M, Tilley SL, Morham SG, Langenbach R, Stock JL, McNeish JD, Smithies O, Coffman TM, Koller BH (2004) E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 173(2):1321–1326
Acknowledgments
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this chapter
Cite this chapter
Honda, T., Kabashima, K. (2015). Lipid Mediators and Skin Diseases. In: Yokomizo, T., Murakami, M. (eds) Bioactive Lipid Mediators. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55669-5_21
Download citation
DOI: https://doi.org/10.1007/978-4-431-55669-5_21
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55668-8
Online ISBN: 978-4-431-55669-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)